WO2024218697 - METHODS AND SYSTEMS FOR IMPROVING ANTI-CANCER THERAPIES
National phase entry:
Publication Number
WO/2024/218697
Publication Date
24.10.2024
International Application No.
PCT/IB2024/053769
International Filing Date
17.04.2024
Title **
[English]
METHODS AND SYSTEMS FOR IMPROVING ANTI-CANCER THERAPIES
[French]
MÉTHODES ET SYSTÈMES POUR AMÉLIORER DES THÉRAPIES ANTICANCÉREUSES
Applicants **
OSASUNA THERAPEUTICS SA
INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE
UNIVERSITÉ PARIS CITÉ
SORBONNE UNIVERSITÉ
ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS
INSTITUT GUSTAVE ROUSSY
Inventors
DE BOER, Mark
KROEMER, Guido
MONTEGUT, Léa
MARTINS, Isabelle
PAN, Hui
CHEN, Hui
LI, Sijing
Priority Data
23168612.2
18.04.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 7520 | |
| EPO | Filing, Examination, Granting | 189728 | |
| Japan | Filing, Examination, Granting | 5289 | |
| South Korea | Filing, Examination, Granting | 11229 | |
| USA | Filing, Examination, Granting | 45490 |
Total:
259,256
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure provides improved methods, compositions, agents, therapeutic regimens, and systems for cancer treatment, such as improving the outcome of chemo- and/or immunotherapies, and/or inducing autophagy in subjects through the inhibition of extracellular diazepam binding inhibitor (DBI) by various methods.[French]
La présente divulgation concerne des méthodes, compositions, agents, régimes thérapeutiques et systèmes améliorés pour le traitement du cancer, tels que l'amélioration du résultat de chimiothérapies et/ou d'immunothérapies, et/ou l'induction de l'autophagie chez des sujets par l'inhibition d'un inhibiteur de liaison de diazépam extracellulaire (DBI) par diverses méthodes.